176 related articles for article (PubMed ID: 10385079)
1. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
Hadley GA; Rostapshova EA; Gomolka DM; Taylor BM; Bartlett ST; Drachenberg CI; Weir MR
Transplantation; 1999 Jun; 67(11):1418-25. PubMed ID: 10385079
[TBL] [Abstract][Full Text] [Related]
2. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
[TBL] [Abstract][Full Text] [Related]
4. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
Hadley GA; Charandee C; Weir MR; Wang D; Bartlett ST; Drachenberg CB
Transplantation; 2001 Nov; 72(9):1548-55. PubMed ID: 11707744
[TBL] [Abstract][Full Text] [Related]
5. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
6. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
7. Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade.
Robertson H; Wong WK; Talbot D; Burt AD; Kirby JA
Transplantation; 2001 Jan; 71(2):306-13. PubMed ID: 11213078
[TBL] [Abstract][Full Text] [Related]
8. Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity.
Smyth LJ; Kirby JA; Cunningham AC
Clin Exp Immunol; 2007 Jul; 149(1):162-70. PubMed ID: 17403056
[TBL] [Abstract][Full Text] [Related]
9. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.
Feng Y; Wang D; Yuan R; Parker CM; Farber DL; Hadley GA
J Exp Med; 2002 Oct; 196(7):877-86. PubMed ID: 12370250
[TBL] [Abstract][Full Text] [Related]
10. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation.
Yuan R; El-Asady R; Liu K; Wang D; Drachenberg CB; Hadley GA
J Immunol; 2005 Sep; 175(5):2868-79. PubMed ID: 16116173
[TBL] [Abstract][Full Text] [Related]
11. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
13. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells.
Uss E; Rowshani AT; Hooibrink B; Lardy NM; van Lier RA; ten Berge IJ
J Immunol; 2006 Sep; 177(5):2775-83. PubMed ID: 16920912
[TBL] [Abstract][Full Text] [Related]
14. Integrin-mediated interactions influence the tissue specificity of CD8+ cytolytic T lymphocytes.
Rostapshova EA; Burns JM; Bartlett ST; Hadley GA
Eur J Immunol; 1998 Oct; 28(10):3031-9. PubMed ID: 9808171
[TBL] [Abstract][Full Text] [Related]
15. TGF-β: Many Paths to CD103
Qiu Z; Chu TH; Sheridan BS
Cells; 2021 Apr; 10(5):. PubMed ID: 33922441
[TBL] [Abstract][Full Text] [Related]
16. Role of integrin CD103 in promoting destruction of renal allografts by CD8 T cells.
Hadley G
Am J Transplant; 2004 Jul; 4(7):1026-32. PubMed ID: 15196058
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human mucosal lymphocyte antigen, HML-1, by T cells activated with mitogen or specific antigen in vitro.
Brew R; West DC; Burthem J; Christmas SE
Scand J Immunol; 1995 Jun; 41(6):553-62. PubMed ID: 7770725
[TBL] [Abstract][Full Text] [Related]
18. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD103 expression on human colon carcinoma-specific CTL.
Ling KL; Dulphy N; Bahl P; Salio M; Maskell K; Piris J; Warren BF; George BD; Mortensen NJ; Cerundolo V
J Immunol; 2007 Mar; 178(5):2908-15. PubMed ID: 17312135
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen-induced regulatory CD8+CD103+ T cells.
Koch SD; Uss E; van Lier RA; ten Berge IJ
Hum Immunol; 2008 Nov; 69(11):737-44. PubMed ID: 18822329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
